Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2024-11-01 00:00:00 ET · period of report 2024-10-30 · accession 0001628280-24-044814 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-01 | 2024-10-30 | BLFS | Berard Todd | CMO | S - Sale | $23.15 | -311 | 107.8K | -0.3% | -$7,200 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-30 | S | D | 311 | $23.15 | 107,847 | D | — | — |